Early Diagnosis of Diabetes

Our diabetes early diagnosis program

MAPFRE has designed an early diagnosis program for diabetes, aimed at risk groups, and any insured who wants to know their situation in relation to this pathology.

The program, performed by some Company services (so it is desirable to contact the Company's medical services in your province) includes:

• A risk assessment questionnaire.
• A consultation and examination by an endocrinologist.
• An EKG and fundus.
• A specific analysis.
• A clinical report with the risk assessment and the precise recommendations.

We trust that this program for the early diagnosis of diabetes help to detect ‘Unknown diabetes’, and to reduce the frequent complications that this disease causes when it is not adequately controlled.

Why has MAPFRE decided to create this program?

diabetes is a silent disease. The patient can have it for years and not know it. During this time, the eyes, nerves, and kidneys may have suffered damage from high blood sugar, which in most cases is irreversible.

• Eye disease: 20-30% of registered blindness are attributable to diabetic retinopathy, being the leading cause of blindness in industrialized countries. Diabetic retinopathy is estimated to affect 40-50% of all patients with diabetes.
• Kidney disease: 30-40% of patients with more than 20 years of evolution present some degree of kidney involvement.
• Neuropathy: Approximately 60-70% of patients with diabetes have some degree of neuropathy. Sexual impotence affects almost 40% of men with diabetes.
• cardiovascular disease: The risk of developing coronary, brain or peripheral disease is 2-4 times higher in diabetics (2 times higher in men and 4 times higher in women). Approximately 50% of non-traumatic lower limb amputations are performed in patients with diabetes.
• Pregnancy: The rate of congenital malformations in newborns of diabetic mothers (pregestational diabetes) ranges from 0-5% in women with control before becoming pregnant, to 10% in women who have not had this control.

The importance of this disease

• Patients with diabetes diagnosed before the age of 15 have a mortality rate 11 times higher than the general population. Mortality is 2-3 times higher in patients diagnosed with diabetes after 40 years of age.
• In most developed countries, the diabetes it ranks from 4th to 8th place among causes of death. In Spain it represents the 3rd cause in women and the 7th in men.
• In European countries the mortality rate ranges between 7.9 and 32.2 / 100,000 inhabitants. In Spain it oscillates around 23.2 / 100,000 inhabitants. In most studies, the rates are higher for women than for men (in Spain, 29.3 versus 16.1).
• The leading cause of death among patients with diabetes is the one that causes 50-60% of deaths in patients with DM2. The main cause of death in patients with DM1 is renal failure due to diabetic nephropathy.

The Insurances have other Preventive Medicine Programs so that you feel safe at all times.